July 21, 2021 Acad, Gov/Utilities Other Lab Products/Services PAI Top-10

FDA grants Breakthrough Therapy Designation for Venclexta in combination with azacitidine for the treatment of patients with myelodysplastic syndromes

Every year in the US, approximately 10,000 people are diagnosed with myelodysplastic syndromes (MDS), and there remains a high unmet need for new treatment options1 The designation is based on interim results from the phase Ib M15-531 study investigating Venclexta/Venclyxto plus azacitidine in people with previously untreated higher-risk MDS This is the 11th Breakthrough Therapy... Read more

July 20, 2021 Life Science Tools Liq. Handling & Robotics PR/Corporate

Brooks Automation Announces Fiscal 2021 Third Quarter Earnings Conference Call and Webcast

Brooks Automation Announces Fiscal 2021 Third Quarter Earnings Conference Call and Webcast CHELMSFORD, Mass., July 20, 2021 /PRNewswire/ — Brooks Automation, Inc. (Nasdaq: BRKS) will announce fiscal 2021 third quarter which ended on June 30, 2021 on Thursday, August 5, 2021 after the market closes. The Company will host a conference call and live webcast to... Read more

July 20, 2021 M&A, Partnerships

Pacific Biosciences and Invitae Announce Intent to Expand Collaboration

Collaboration to develop production-scale HiFi Sequencing platformexpected to Include technology from Omniome, Inc. Combining both highly accurate long and short read sequencing technologies expected to provide deeper clinical insights and lower the overall cost of analysis MENLO PARK, Calif., July 20, 2021 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq: PACB)(“Pacific Biosciences” or “PacBio”),... Read more

July 20, 2021 M&A, Partnerships

Pacific Biosciences Signs Definitive Agreement to Acquire Omniome

Combination aims to transform the genomics landscape and deliver a differentiated product offering into high growth clinical markets Brings together Omniome’s high accuracy short-read sequencing platform, with PacBio’s market leading, high accuracy long-read solutions Transaction supported by concurrent $300 million PIPE financing from premier life science investors MENLO PARK, Calif. and SAN DIEGO, July 20,... Read more

July 20, 2021 Uncategorized

Japan becomes first country to approve Ronapreve (casirivimab and imdevimab) for the treatment of mild to moderate COVID-19

Full approval is based on a global phase III trial which found casirivimab and imdevimab reduced hospitalisation or death by 70% in high-risk non-hospitalised patients Basel, 20 July 2021 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that Japan’s Ministry of Health, Labour and Welfare (MHLW) has approved Ronapreve™(casirivimab and imdevimab), for the treatment... Read more

July 19, 2021 Molecular Spectroscopy PAI Top-10

WITec and attocube launch cryoRaman

Technology leaders combine expertise for very low-temperature Raman imaging Ulm, Germany – Haar, Germany July 20, 2021 Raman imaging innovator WITec GmbH and cryogenic microscopy specialist attocube systems AG have jointly introduced cryoRaman. This cryogenic Raman imaging system integrates attocube’s leading-edge cryostat and nanopositioner technology with the vaunted sensitivity and modularity of WITec’s alpha300 correlative... Read more

July 19, 2021 PR/Corporate

Pacific Biosciences of California, Inc. Second Quarter 2021 Financial Results Call

MENLO PARK, Calif., July 19, 2021 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (NASDAQ: PACB) will hold its quarterly conference call to discuss its second quarter 2021 financial results on Tuesday, August 3, 2021, at 4:30pm Eastern Time. The call will be webcast and may be accessed at Pacific Biosciences’ website at: https://investor.pacificbiosciences.com/. Date:... Read more